agilon health AGL

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.03 (-0.85%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of agilon health (AGL)
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Key Insights

Critical company metrics and information
  • Latest Closing Price

    $3.51
  • Market Cap

    $1.45 Billion
  • Total Outstanding Shares

    412.30 Million Shares
  • Total Employees

    1,076
  • Dividend

    $0.11 Per Share Quarterly
  • IPO Date

    April 15, 2021
  • SIC Description

    Services-misc Health & Allied Services, Nec
  • Primary Exchange

    New York Stock Exchange
  • Type

    Common Stock
  • Headquarters

    6210 e hwy 290, Austin, TX, 78723
  • Homepage

    https://www.agilonhealth.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Financing Activities, Continuing$-2.58 Million
Net Cash Flow From Investing Activities, Continuing$139.89 Million
Net Cash Flow From Operating Activities, Continuing$-57.78 Million
Net Cash Flow From Operating Activities$-57.78 Million
Net Cash Flow, Continuing$79.53 Million
Net Cash Flow$79.53 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Income/Loss Attributable To Noncontrolling Interest$50,000
Benefits Costs and Expenses$6.31 Billion
Diluted Average Shares$410.97 Million
Depreciation and Amortization$24.46 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Basic Average Shares$410.97 Million

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss Attributable To Noncontrolling Interest$50,000
Other Comprehensive Income/Loss$2.21 Million
Comprehensive Income/Loss Attributable To Parent$-257.94 Million
Comprehensive Income/Loss$-257.89 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Assets$1.73 Billion
Liabilities$1.26 Billion
Fixed Assets$28.17 Million
Current Liabilities$1.15 Billion
Equity Attributable To Noncontrolling Interest$0
Equity$470.95 Million

Historical Dividends

Current dividend: $0.11 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about AGL from trusted financial sources